A proton pump inhibitor, E3810, has antibacterial activity through binding toHelicobacter pylori
- 1 August 1995
- journal article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 30 (4), 461-464
- https://doi.org/10.1007/bf02347561
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanismGastroenterology, 1994
- Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.1994
- Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cellsAntimicrobial Agents and Chemotherapy, 1993
- Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori.Journal of Clinical Pathology, 1992
- Effects of the Proton Pump Inhibitor, E3810, on Gastric Secretion and Gastric and Duodenal Ulcers or Erosions in RatsClinical Drug Investigation, 1991
- Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 1991
- Cure of duodenal ulcer associated with eradication of Helicobacter pyloriThe Lancet, 1990
- PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORIThe Lancet, 1988
- Gastric Campylobacter-like organisms, gastritis, and peptic ulcer diseaseGastroenterology, 1987
- SOME PHYSICAL CHEMICAL ASPECTS OF “PLASMA EXTENDERS”Annals of the New York Academy of Sciences, 1952